🇺🇸 FDA
Patent

US 8871209

Compositions and methods for increasing muscle mass and muscle strength by specifically antagonizing GDF8 and or Activin A

granted A61KA61K2039/505A61K2039/507

Quick answer

US patent 8871209 (Compositions and methods for increasing muscle mass and muscle strength by specifically antagonizing GDF8 and or Activin A) held by REGENERON PHARMACEUTICALS, INC. expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Oct 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K2039/505, A61K2039/507, A61K2039/545, A61K39/3955